- Home
- TECH vs CFR Comparison
TECH vs CFR Comparison
Compare TECH & CFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TECH | CFR |
|---|---|---|
| Founded | 1976 | 1868 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 8.2B |
| IPO Year | 1989 | N/A |
Fundamental Metrics
Financial Performance| Metric | TECH | CFR |
|---|---|---|
| Price | $58.87 | $128.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 14 |
| Target Price | $71.23 | ★ $137.50 |
| AVG Volume (30 Days) | ★ 1.7M | 422.9K |
| Earning Date | 02-04-2026 | 01-29-2026 |
| Dividend Yield | 0.54% | ★ 3.10% |
| EPS Growth | N/A | ★ 20.47 |
| EPS | 0.49 | ★ 9.72 |
| Revenue | $1,216,732,000.00 | ★ $2,141,575,000.00 |
| Revenue This Year | $2.33 | $14.17 |
| Revenue Next Year | $7.05 | $4.47 |
| P/E Ratio | $121.60 | ★ $13.27 |
| Revenue Growth | 3.85 | ★ 9.02 |
| 52 Week Low | $46.01 | $100.31 |
| 52 Week High | $79.28 | $146.44 |
Technical Indicators
Market Signals| Indicator | TECH | CFR |
|---|---|---|
| Relative Strength Index (RSI) | 45.90 | 53.54 |
| Support Level | $56.84 | $127.52 |
| Resistance Level | $59.58 | $130.55 |
| Average True Range (ATR) | 1.72 | 2.27 |
| MACD | -0.08 | -0.06 |
| Stochastic Oscillator | 44.22 | 45.62 |
Price Performance
Historical ComparisonAbout TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $53 billion in assets (as of September 2025), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.